LRCX 8-K Current Reports
LAM RESEARCH CORP - 304 current reports
LAM RESEARCH CORP 8-K Report, Financial Results (Apr 22, 2026)
Lam Research Corporation (LRCX) has filed a Form 8-K on April 22, 2026, to announce its financial results for the fiscal quarter ended March 29, 2026. This filing primarily serves to furnish the press release detailing these results, which is attached as Exhibit 99.1. Investors should note that this information is furnished and not deemed "filed" for regulatory purposes, meaning it does not carry the same liability under Section 18 of the Exchange Act. The press release, found in Exhibit 99.1, contains the core financial and operational performance data for the quarter. While specific figures are not detailed in the 8-K body itself, the press release is the definitive source for key metrics such as revenue, profitability, and any forward-looking guidance provided by the company.
LAM RESEARCH CORP 8-K/A Report, Executive Changes (Feb 4, 2026)
Lam Research Corporation (LRCX) announced a significant board refreshment and a key executive transition. Anirudh Devgan, Ph.D., CEO of Cadence Design Systems, has been appointed to the Board of Directors, effective immediately. This appointment aims to strengthen the board's expertise, particularly within the Innovation and Technology Committee, leveraging Dr. Devgan's extensive experience in computational software and electronic design automation. His background at Cadence and prior roles at Magma Design Automation and IBM bring a wealth of industry knowledge. Concurrently, the company is undergoing a leadership change in its operations. Patrick J. Lord, Ph.D., is retiring as Chief Operating Officer after a long tenure, and Seshasayee (Sesha) Varadarajan will assume the COO role effective March 6, 2026. Mr. Varadarajan is a seasoned executive within Lam Research, having held various senior leadership positions in product groups and business units, including his most recent role as Senior Vice President of the Global Products Group. These changes reflect a strategic move to integrate new perspectives at the board level while promoting internal talent to key operational leadership positions.
LAM RESEARCH CORP 8-K Report, Executive Changes (Feb 3, 2026)
Lam Research Corporation (LRCX) has announced a significant board and executive leadership transition. Effective immediately, Anirudh Devgan, Ph.D., CEO of Cadence Design Systems, has been appointed as a new director to the Board, increasing its size by one. Dr. Devgan brings extensive experience in the semiconductor design software industry, including his current role and prior leadership positions at Cadence and Magma Design Automation. His appointment to the Innovation and Technology Committee is expected to bolster the company's strategic direction in technological advancements. Concurrently, the company is undergoing an executive transition in its operational leadership. Patrick J. Lord, Ph.D., current Chief Operating Officer, will retire effective March 6, 2026, after over two decades of service. Succeeding him in this role will be Seshasayee (Sesha) Varadarajan, currently Senior Vice President of the Global Products Group. Mr. Varadarajan has a long tenure with Lam Research and its predecessor Novellus Systems, with deep experience across product groups, particularly in deposition technologies. These changes, announced via press release on February 3, 2026, signal a blend of new strategic oversight and continuity in operational leadership for Lam Research.
LAM RESEARCH CORP 8-K Report, Financial Results (Jan 28, 2026)
Lam Research Corporation (LRCX) has filed an 8-K report on January 28, 2026, to announce its financial results for the fiscal quarter ended December 28, 2025. The key information is contained within the attached press release (Exhibit 99.1), which provides the company's performance metrics for the specified period. Investors should refer to this press release for detailed financial data, including revenue, profitability, and other key operational indicators. This filing serves as a standard update for investors, outlining the company's recent financial condition and operational outcomes. While the 8-K itself is procedural, the attached press release is the primary source of investor-relevant financial performance information for the quarter. The company emphasizes that the information furnished in this report is not deemed "filed" for certain regulatory purposes, which is a common disclaimer for such filings.
LAM RESEARCH CORP 8-K Report, Rights Modification (Nov 6, 2025)
Lam Research Corporation (LRCX) filed an 8-K report on November 5, 2025, detailing outcomes from its annual stockholders' meeting held on November 3, 2025. The key events include the approval of the new 2025 Stock Incentive Plan, which is designed to incentivize and retain key employees through equity awards. Additionally, stockholders approved an amendment to the company's Restated Certificate of Incorporation to limit the liability of certain officers, aligning with provisions allowed under Delaware law. Furthermore, the report confirms the election of all nominated directors, with overwhelming support for most nominees. The advisory vote on executive compensation ('Say on Pay') and the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026 also received strong approval from shareholders. A shareholder proposal seeking to enable a special shareholder meeting was not approved.
LAM RESEARCH CORP 8-K Report, Financial Results (Oct 22, 2025)
Lam Research Corporation (LRCX) has filed an 8-K to report its financial results for the fiscal quarter ended September 28, 2025. This filing primarily consists of a press release providing these results, which investors should review for detailed financial performance, including revenue, earnings per share, and any management commentary on market conditions and future outlook. The report does not contain new material events beyond the financial results announcement itself.
LAM RESEARCH CORP 8-K Report, Auditor Change (Sep 11, 2025)
Lam Research Corporation (LRCX) announced a significant change in its independent auditor, dismissing Ernst & Young LLP (EY) and engaging KPMG LLP (KPMG) for the fiscal year 2026 audit, effective September 8, 2025. This change is a routine transition, as the company explicitly stated that there were no disagreements or reportable events with EY during their tenure covering fiscal years 2024 and 2025, and the preceding interim period. The dismissal and engagement were approved by the Audit Committee of the Board of Directors. Investors should note that this filing is primarily administrative and focuses on the change in accounting firms. The company has provided the required disclosures regarding the transition, including a letter from EY to the SEC confirming their agreement with the statements made by Lam Research. The engagement of KPMG signals a new relationship for the company's financial audits going forward, which is a standard practice for public companies to periodically rotate auditors.
LAM RESEARCH CORP 8-K Report, Financial Results (Jul 30, 2025)
Lam Research Corporation (LRCX) has filed an 8-K report on July 30, 2025, to announce its financial results for the fiscal quarter ended June 29, 2025. The filing primarily contains a press release detailing these results, which provides investors with an update on the company's operational and financial performance during the period. While the full financial details are within the attached press release (Exhibit 99.1), this 8-K serves as the official notification of the release of this information to the market. Investors should refer to Exhibit 99.1 for specific revenue, profit, and segment performance data. This report does not contain new material business events beyond the financial results announcement. As this information is furnished and not filed, it is important for investors to note that it does not carry the same legal implications as a "filed" document under Section 18 of the Exchange Act.
LAM RESEARCH CORP 8-K Report, Bylaw Amendment (May 21, 2025)
Lam Research Corporation (LRCX) announced a significant amendment to its corporate governance through the adoption of new Amended and Restated Bylaws, effective May 20, 2025. The key change empowers a group of substantial stockholders, defined as those holding at least 20% of outstanding common stock continuously for a year, with the ability to call a special meeting. This provision is accompanied by specific disclosure, timing, and procedural requirements designed to ensure transparency and prevent the unnecessary duplication of stockholder meetings.
LAM RESEARCH CORP 8-K Report, Financial Results (Apr 23, 2025)
Lam Research Corporation (LRCX) has filed a Form 8-K on April 23, 2025, to announce its financial results for the fiscal quarter ended March 30, 2025. The filing primarily includes a press release detailing these financial outcomes, which investors should review for the latest performance metrics and forward-looking statements. While the specific financial figures are contained within the attached press release (Exhibit 99.1), this 8-K serves as the official notification of the results. Investors are advised to consult the press release for details on revenue, earnings per share, gross margins, and any management commentary on business trends, market conditions, and the company's outlook. This filing is furnished and not deemed to be 'filed' for certain SEC purposes.
LAM RESEARCH CORP 8-K Report, Material Agreement (Jan 29, 2025)
Lam Research Corporation (LRCX) has entered into a Third Amended and Restated Credit Agreement, significantly enhancing its financial flexibility. This agreement increases the company's revolving unsecured credit facility from $1.5 billion to $2.0 billion, with an option to further expand it by an additional $750 million, potentially bringing the total commitment to $2.750 billion. The facility now matures on January 25, 2030, providing long-term access to capital for general corporate purposes. This updated credit facility reflects the company's strong financial standing and its proactive approach to managing its capital structure. The terms include competitive interest rates based on the company's credit rating and a key financial covenant requiring a consolidated funded debt to adjusted EBITDA ratio of less than or equal to 3.50 to 1.00 (which can temporarily increase to 4.00 to 1.00 in connection with acquisitions). As of the filing date, no amounts were outstanding under the facility, indicating a strong liquidity position.
LAM RESEARCH CORP 8-K Report, Financial Results (Jan 29, 2025)
Lam Research Corporation (LRCX) has filed a Form 8-K to announce its financial results for the fiscal quarter ended December 29, 2024. The filing primarily serves to attach the press release detailing these results, which was issued on January 29, 2025. Investors should refer to the attached Exhibit 99.1 for comprehensive details on the company's performance during this period. This report indicates that the company has met its reporting obligations regarding its financial performance. While the 8-K itself does not contain detailed financial figures, it directs stakeholders to the accompanying press release for insights into revenue, earnings, and any forward-looking statements or strategic updates. Investors are encouraged to review the press release for a complete understanding of LRCX's operational and financial condition for the reported quarter.
LAM RESEARCH CORP 8-K Report, Shareholder Vote Results (Nov 7, 2024)
Lam Research Corporation (LRCX) has filed an 8-K report detailing the outcomes of its Annual Meeting of Stockholders held on November 5, 2024. The key takeaway for investors is the strong shareholder support for the company's governance and executive compensation practices. All nominated directors were overwhelmingly re-elected, indicating confidence in the current leadership and strategic direction. Furthermore, the 'Say on Pay' proposal, which provides an advisory vote on executive compensation, also received substantial approval, reflecting shareholder agreement with the company's compensation philosophy. In addition to governance matters, shareholders also ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for fiscal year 2025. This strong endorsement across all submitted proposals suggests a stable and supportive shareholder base, which is generally viewed positively by the market and can contribute to continued operational execution and investor confidence.
LAM RESEARCH CORP 8-K Report, Financial Results (Oct 23, 2024)
Lam Research Corporation (LRCX) filed an 8-K on October 23, 2024, to announce its financial results for the fiscal quarter ended September 29, 2024. The core of this filing is the press release attached as Exhibit 99.1, which details the company's performance during the reported period. Investors should refer to this press release for specific financial metrics, including revenue, profitability, and any forward-looking guidance provided by management. This 8-K filing serves as a formal notification of these results and highlights the company's operational and financial standing. While the 8-K itself is brief, the attached press release contains the detailed financial information that investors will scrutinize to assess the company's trajectory and its ability to meet market expectations. Investors are encouraged to review Exhibit 99.1 directly for a comprehensive understanding of these results and their implications.
LAM RESEARCH CORP 8-K Report, Rights Modification (Oct 2, 2024)
Lam Research Corporation (LRCX) has filed an 8-K report detailing a significant corporate action: a ten-for-one forward stock split. This split, effective October 2, 2024, will increase the number of outstanding shares by a factor of ten, while proportionally increasing the authorized share capital from 400 million to 4 billion shares. Importantly, this action does not alter the par value of the common stock or the fundamental rights and preferences of shareholders. This strategic move aims to make the company's stock more accessible to a broader range of investors by reducing the per-share trading price. The stock split is expected to take effect for trading purposes on October 3, 2024, under the same ticker symbol 'LRCX'. Investors holding LRCX will see their share count multiplied by ten, with corresponding adjustments to equity awards and options.
LAM RESEARCH CORP 8-K Report, Corporate Update (Sep 25, 2024)
Lam Research Corporation (LRCX) has filed an 8-K to provide investors with an update on its previously announced ten-for-one forward stock split. The primary purpose of this filing is to announce the new CUSIP number for the company's common stock, which will be 512807306, effective after the stock split. This stock split is scheduled to become effective at 5:00 p.m. Eastern Time on October 2, 2024, with trading expected to commence on a split-adjusted basis on October 3, 2024. Investors holding shares through a broker or electronically in book-entry form will have their shares automatically adjusted and will not need to take any action. Registered stockholders with physical certificates will need to surrender them to the transfer agent, Computershare, via a letter of transmittal to receive their post-split shares.
LAM RESEARCH CORP 8-K Report, Executive Changes (Sep 18, 2024)
Lam Research Corporation (LRCX) announced in an 8-K filing dated September 17, 2024, that two long-serving members of its Board of Directors, Lih Shyng (Rick L.) Tsai, Ph.D. and Leslie F. Varon, will be concluding their service. Their departure is scheduled for November 4, 2024, just before the Company's 2024 annual meeting of stockholders. Consequently, neither Dr. Tsai nor Ms. Varon will be standing for re-election at the upcoming annual meeting on November 5, 2024. The company expressed its gratitude for their substantial contributions during their tenures. While the filing does not provide specific reasons for their departures, the conclusion of service for two directors typically signals a transition period for the board. Investors should monitor future filings for any information regarding the replacement of these directors and any strategic implications that might arise from these changes. The company's management has acknowledged their dedicated service, highlighting their significant contributions.
LAM RESEARCH CORP 8-K Report, Executive Changes (Aug 30, 2024)
Lam Research Corporation (LRCX) has announced a significant expansion of its Board of Directors with the appointment of two new independent directors, Ita M. Brennan and Mark Fields, effective August 30, 2024. This move increases the board size by two members and signals a commitment to strengthening governance and strategic oversight. Both appointees bring extensive experience in finance, executive leadership, and board service across various prominent technology and industrial companies, which is expected to be valuable as LRCX navigates the complex semiconductor industry landscape. Ms. Brennan, a former CFO at Arista Networks and QuantumScape, brings deep financial expertise and audit committee experience, with current roles at Planet Labs and Cadence Design Systems. Mr. Fields, a former CEO of Ford Motor Company and Senior Advisor at TPG Capital, offers broad operational and strategic leadership insights, with current board positions at Qualcomm and Hertz. These appointments are part of the company's standard director compensation and indemnification policies, and their addition is designed to enhance the board's collective capabilities.
LAM RESEARCH CORP 8-K Report, Financial Results (Jul 31, 2024)
Lam Research Corporation (LRCX) filed an 8-K on July 30, 2024, to report its financial results for the fiscal quarter ended June 30, 2024. The filing primarily consists of a press release detailing these results, which is attached as Exhibit 99.1. This press release is the key source of financial information for investors from this filing, providing details on the company's performance during the quarter. Investors should refer to the attached press release for specific revenue, earnings, and other key financial metrics. This 8-K serves as notification and disclosure of the company's most recent financial performance. While the 8-K itself doesn't contain the detailed financial tables, it directs investors to the exhibit that does. The information provided is furnished and not deemed 'filed' for certain regulatory purposes, a standard disclosure for such announcements.
LAM RESEARCH CORP 8-K Report, Regulation FD Disclosure (May 21, 2024)
Lam Research Corporation (LRCX) announced a significant capital allocation decision via an 8-K filing on May 21, 2024. The company's Board of Directors has authorized a 10-for-1 forward stock split, which is expected to become effective after market close on October 2, 2024, with trading on a split-adjusted basis commencing October 3, 2024. This move is primarily aimed at making the stock more accessible to a broader range of investors. In addition to the stock split, Lam Research also unveiled a substantial new share repurchase program, authorizing the buyback of up to $10 billion of its common stock. This dual announcement signals strong confidence from management in the company's future prospects and a commitment to returning value to shareholders.
LAM RESEARCH CORP 8-K Report, Financial Results (Apr 24, 2024)
Lam Research Corporation (LRCX) filed an 8-K on April 24, 2024, to report its financial results for the fiscal quarter ended March 31, 2024. The filing primarily consists of a press release that details the company's performance and financial condition for the reported period. Investors should note that this information is furnished and not deemed "filed" for regulatory purposes, meaning it's provided for informational transparency but doesn't carry the same liability as formally filed data under Section 18 of the Exchange Act.
LAM RESEARCH CORP 8-K Report, Financial Results (Jan 24, 2024)
Lam Research Corporation (LRCX) filed an 8-K on January 24, 2024, to announce its financial results for the fiscal quarter ended December 24, 2023. This filing primarily serves to furnish the press release containing these results, as stipulated by Item 2.02 of the 8-K form. Investors should refer to the attached Exhibit 99.1 for the detailed financial performance and operational updates for the specified quarter. The information provided in this 8-K is crucial for understanding the company's recent financial health and performance trends. While the 8-K itself is a procedural filing, the attached press release contains the core financial data, including revenue, profitability, and potentially forward-looking statements or management commentary. Investors are advised to examine Exhibit 99.1 closely for insights into Lam Research's operational execution and its outlook within the semiconductor equipment industry.
LAM RESEARCH CORP 8-K Report, Bylaw Amendment (Nov 9, 2023)
Lam Research Corporation (LRCX) filed an 8-K on November 8, 2023, detailing amendments to its Amended and Restated Bylaws, effective immediately. These changes are primarily administrative and designed to align with updated Delaware corporate law and SEC/Nasdaq regulations. Key amendments include modifications to procedures for adjourning stockholder meetings, proxy card color requirements, removal of the mandatory physical stockholder list at meetings, and ensuring the company is not obligated to indemnify officers for erroneously awarded compensation in compliance with SEC's clawback rules. The filing also reported the results of the company's Annual Meeting of Stockholders held on November 7, 2023. Investor-focused insights from the meeting results show overwhelming support for all director nominees, with vote percentages generally above 88% (with several above 99%). The "Say on Pay" advisory vote to approve executive compensation also passed with strong approval (95.21% for). Furthermore, the advisory vote on the frequency of "Say on Pay" votes overwhelmingly favored an annual vote (98.64% for one year), and the Board has committed to holding such advisory votes annually until at least 2029. The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2024 was also ratified with significant shareholder support.
LAM RESEARCH CORP 8-K Report, Financial Results (Oct 18, 2023)
Lam Research Corporation (LRCX) filed an 8-K on October 17, 2023, to announce its financial results for the fiscal quarter ended September 24, 2023. The press release, attached as Exhibit 99.1, provides key financial performance indicators for the period. Investors should note that this information is furnished and not deemed "filed" for certain regulatory purposes. This filing primarily serves to make the company's latest quarterly financial results publicly available. While the specific financial figures are not detailed within the 8-K text itself, the attached press release contains the substantive results. Investors seeking detailed performance metrics, such as revenue, earnings per share, and forward-looking guidance, will need to refer to the Exhibit 99.1.
LAM RESEARCH CORP 8-K Report, Executive Changes (Aug 24, 2023)
Lam Research Corporation (LRCX) announced a significant board refreshment with the appointment of John M. Dineen as a new director, effective August 24, 2023. Mr. Dineen brings extensive leadership experience from his tenure at General Electric, including serving as President and CEO of GE Healthcare and GE Transportation, and his recent role as an Operating Advisor at Clayton, Dubilier & Rice. His appointment expands the board to eleven members and he will join the Audit Committee in November 2023. Mr. Dineen's diverse background in global operations, technology, and previous board experience with publicly traded and private companies, such as Cognizant Technology Solutions and Syneos Health, is expected to provide valuable strategic insights. Investors can view this as a move to enhance board expertise and governance. Mr. Dineen's compensation will align with the company's standard director compensation policies, and he will be subject to the company's standard indemnification agreement.
LAM RESEARCH CORP 8-K Report, Financial Results (Jul 26, 2023)
Lam Research Corporation (LRCX) filed an 8-K on July 26, 2023, to announce its financial results for the fiscal quarter ended June 25, 2023. The report itself is brief, primarily referencing an attached press release (Exhibit 99.1) which contains the detailed financial and operational information. Investors should refer to this press release for specific figures related to revenue, earnings, and any forward-looking statements or business outlook provided by the company. The filing serves as the official notification of the company's performance for the period. While the 8-K document itself does not contain the financial numbers, it is the mandatory SEC filing that signals the release of this crucial information. The disclaimer included indicates that the information furnished is for informational purposes and not subject to certain liabilities of the Exchange Act, a standard practice for earnings release disclosures.
LAM RESEARCH CORP 8-K Report, Financial Results (Apr 19, 2023)
Lam Research Corporation (LRCX) filed an 8-K on April 19, 2023, to announce its financial results for the fiscal quarter ended March 26, 2023. This filing primarily serves to attach the press release containing these results, which is incorporated by reference. Investors should refer to the attached Exhibit 99.1 for the detailed financial performance and operational updates for the period. The information furnished in this 8-K is for informational purposes and is not considered "filed" under Section 18 of the Exchange Act, nor is it incorporated into other SEC filings. This means the company is providing these results to the public but is not undertaking the same level of legal responsibility as if it were a fully "filed" document. The core financial figures and commentary are found within the press release itself, making it the primary source of information for understanding LRCX's performance during the quarter.
LAM RESEARCH CORP 8-K Report, Executive Changes (Feb 21, 2023)
Lam Research Corporation (LRCX) has announced significant leadership changes within its executive team. Effective March 1, 2023, Patrick J. Lord, Ph.D. has been appointed as the new Executive Vice President and Chief Operating Officer. Dr. Lord brings extensive experience from his previous roles within the company, including leading the Customer Support Business Group and Global Operations, as well as prior leadership positions at Novellus Systems and KLA-Tencor. Concurrently, Christina (Tina) C. Correia has been appointed as the Chief Accounting Officer. Ms. Correia, who has been with Lam Research since 2002 and most recently served as Corporate Vice President of Corporate Finance and Investor Relations, will also retain her current responsibilities. These appointments reflect the company's strategy to leverage internal talent for key operational and financial oversight roles.
LAM RESEARCH CORP 8-K Report, Executive Changes (Feb 9, 2023)
Lam Research Corporation (LRCX) announced a significant addition to its Board of Directors with the appointment of Ho Kyu Kang, effective February 7, 2023. Dr. Kang brings extensive experience in the semiconductor industry, having held senior leadership roles at Samsung Electronics for over two decades, specializing in research and development, process development, and technology innovation. His academic background, including a Ph.D. from Stanford University, and prior board experience with semiconductor research consortia, will undoubtedly enhance the company's strategic direction and technological insight. In addition to the board appointment, the company's Compensation and Human Resources Committee amended and restated the 2004 Executive Incentive Plan. These amendments primarily involve clarifying that awards are subject to the company's clawback policy and removing provisions related to a now-repealed IRS tax code exception, reflecting administrative and regulatory updates. Investors should note that Dr. Kang's appointment is routine and he will receive standard director compensation and an indemnification agreement.
LAM RESEARCH CORP 8-K Report, Financial Results (Jan 25, 2023)
Lam Research Corporation (LRCX) filed an 8-K on January 24, 2023, reporting its financial results for the fiscal quarter ended December 25, 2022, and announcing a significant restructuring plan. While specific financial figures for the quarter are referenced via an attached press release (Exhibit 99.1), the 8-K itself focuses on a workforce reduction initiative. This restructuring involves approximately 1,300 employee positions, representing about 7% of the company's workforce, and is expected to be substantially completed by the end of June 2023. The company anticipates incurring approximately $80.0 million in charges, primarily related to one-time termination benefits, during the quarter ending March 26, 2023. Management indicates these actions are intended to align the cost structure with the current economic outlook and future business opportunities, with potential for further cost reduction activities in the next twelve months.
LAM RESEARCH CORP 8-K Report, Shareholder Vote Results (Nov 10, 2022)
Lam Research Corporation (LRCX) held its Annual Meeting of Stockholders on November 8, 2022, where several key proposals were voted upon. The results indicate strong shareholder support for the company's governance and executive compensation practices. All nominated directors were overwhelmingly elected, reflecting confidence in the leadership team's ability to guide the company forward. Furthermore, shareholders approved the executive compensation program on an advisory basis ('Say on Pay') with a significant majority, signaling alignment between the company's pay practices and shareholder interests. The company also secured broad ratification for its choice of independent registered public accounting firm, Ernst & Young LLP, for the upcoming fiscal year 2023, underscoring confidence in the integrity and accuracy of its financial reporting.
LAM RESEARCH CORP 8-K Report, Financial Results (Oct 19, 2022)
Lam Research Corporation (LRCX) filed an 8-K on October 19, 2022, to announce its financial results for the fiscal quarter ended September 25, 2022. The filing includes a press release detailing these results, which is furnished and not deemed officially filed under SEC regulations. This report serves as the primary channel for investors to access the company's performance metrics for the period. While the specific financial figures are contained within the attached press release (Exhibit 99.1), the essence of this filing is the disclosure of operational and financial outcomes for the quarter. Investors should review the accompanying press release for details on revenue, profitability, and any forward-looking statements or guidance provided by the company. This information is crucial for assessing LRCX's current financial health and future prospects.
LAM RESEARCH CORP 8-K Report, Executive Changes (Sep 19, 2022)
Lam Research Corporation (LRCX) announced on September 18, 2022, that Director Catherine P. Lego will be retiring from the Board of Directors. Her retirement is effective November 7, 2022, which is prior to the company's 2022 annual meeting of stockholders. This change in board composition, while not indicating any adverse events, is a notable event for the company's governance structure. Investors should monitor the company's upcoming filings for information regarding the replacement of Ms. Lego on the Board. The departure of a director can sometimes signal shifts in strategic focus or governance approach, although in this instance, it is presented as a retirement. The effective date allows for a smooth transition period before the annual meeting.
LAM RESEARCH CORP 8-K Report, Financial Results (Jul 27, 2022)
Lam Research Corporation (LRCX) filed an 8-K on July 27, 2022, to report its financial results for the fiscal quarter ended June 26, 2022. The press release, attached as Exhibit 99.1, provides key financial and operational performance data. Investors should note that this information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act, meaning it carries different legal implications regarding liability. The core purpose of this filing is to disseminate the company's latest quarterly performance figures. While the 8-K itself is brief, the attached press release will contain the critical details regarding revenue, profitability, and any forward-looking guidance the company is providing. Investors will need to review Exhibit 99.1 for the specific financial metrics and management commentary.
LAM RESEARCH CORP 8-K Report, Executive Changes (May 11, 2022)
Lam Research Corporation (LRCX) filed an 8-K on May 11, 2022, detailing significant corporate governance and capital allocation changes. The Board of Directors approved a new Senior Executive Transition Policy designed to facilitate orderly succession planning and offer eligible senior executives a structured path towards retirement, including phased work arrangements. This policy aims to retain valuable institutional knowledge while ensuring smooth leadership transitions. Additionally, the Company amended and restated its Bylaws to enhance procedural and information requirements for stockholder nominations and proposals, strengthening corporate governance protocols. In a move directly beneficial to shareholders, Lam Research also announced a substantial $5 billion share repurchase authorization. This significant buyback program signals the company's confidence in its financial position and its commitment to returning value to its investors. These actions collectively demonstrate a focus on long-term stability, robust governance, and shareholder returns.
LAM RESEARCH CORP 8-K Report, Financial Results (Apr 20, 2022)
Lam Research Corporation (LRCX) filed an 8-K on April 20, 2022, to announce its financial results for the fiscal quarter ended March 27, 2022. The report primarily consists of a press release detailing these results. While the filing itself does not contain granular financial data, it serves as the official vehicle to furnish this information to the public and the SEC. Investors should refer to the attached Exhibit 99.1, the press release, for specific operational and financial performance metrics, including revenue, earnings, and any forward-looking guidance provided by the company for the upcoming periods. The information furnished under Item 2.02 is not considered 'filed' for liability purposes under Section 18 of the Exchange Act, nor is it incorporated into other SEC filings by reference. This is standard practice for earnings releases. Investors seeking a comprehensive understanding of LRCX's performance and outlook should carefully review the full press release attached as Exhibit 99.1.
LAM RESEARCH CORP 8-K Report, Financial Results (Jan 26, 2022)
Lam Research Corporation (LRCX) filed an 8-K on January 26, 2022, to report its financial results for the fiscal quarter ended December 26, 2021. This filing primarily consists of a press release detailing these results, which is furnished as Exhibit 99.1 and should be reviewed by investors for specific financial performance metrics. The company is providing this information in accordance with Item 2.02 of the 8-K regulations. While the 8-K itself does not contain the detailed financial figures, it serves as the official notification that these results have been released. Investors seeking to understand Lam Research's performance for the quarter should refer to the attached press release (Exhibit 99.1) for information on revenue, profitability, and any forward-looking guidance provided by the company. It's important to note that information furnished under Item 2.02 is not considered "filed" for certain regulatory purposes, meaning it doesn't carry the same liabilities as officially filed information but is crucial for understanding the company's operational and financial standing.
LAM RESEARCH CORP 8-K Report, Executive Changes (Nov 16, 2021)
Lam Research Corporation (LRCX) announced a significant addition to its Board of Directors with the appointment of Jyoti K. Mehra, effective November 9, 2021. Ms. Mehra brings extensive experience in Human Resources, having served in executive roles at Gilead Sciences, Inc. and Novartis Pharmaceuticals Corporation. Her appointment is expected to strengthen the board's expertise in human capital management, a critical area for a global technology company like Lam Research. This appointment increases the size of the board to 10 members. Ms. Mehra will receive standard compensation for non-employee directors and will be subject to the company's standard indemnification agreement. Investors should note that this 8-K filing primarily concerns a board-level appointment and does not include financial performance updates or material changes in company operations.
LAM RESEARCH CORP 8-K Report, Shareholder Vote Results (Nov 12, 2021)
LAM RESEARCH CORP (LRCX) filed an 8-K on November 11, 2021, reporting the results of its Annual Meeting of Stockholders held on November 8, 2021. The primary focus of the filing is the outcome of shareholder votes on key corporate governance matters. All nominated directors were overwhelmingly re-elected, indicating strong shareholder confidence in the current board's leadership and oversight. Additionally, shareholders approved the executive compensation plan on an advisory basis ('Say on Pay') and ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for fiscal year 2022. These results suggest a stable and well-supported governance structure at Lam Research. The high percentages of votes in favor for director nominees and the advisory compensation proposal reflect positive shareholder sentiment regarding the company's strategic direction and management of executive pay. The ratification of the independent auditor further solidifies confidence in the company's financial reporting and controls.
LAM RESEARCH CORP 8-K Report, Financial Results (Oct 20, 2021)
Lam Research Corporation (LRCX) has filed an 8-K report on October 20, 2021, to announce its financial results for the fiscal quarter ended September 26, 2021. This filing primarily serves to attach the press release detailing these results, making the information available to investors. While specific financial figures are not detailed within the 8-K itself, the accompanying press release (Exhibit 99.1) is the key document for investors to understand the company's performance during the period. Investors should refer to the press release issued on October 20, 2021, for a comprehensive overview of Lam Research's financial condition and operational results for the quarter. This includes key metrics such as revenue, profitability, and any forward-looking guidance provided by the company. The 8-K filing's purpose is to officially furnish this information, ensuring it's part of the public record, though it's important to note that this information is furnished and not deemed "filed" under certain sections of the Exchange Act.
LAM RESEARCH CORP 8-K Report, Financial Results (Jul 28, 2021)
Lam Research Corporation (LRCX) filed an 8-K on July 28, 2021, to announce its financial results for the fiscal quarter ended June 27, 2021. The filing primarily serves to attach the press release containing these results, which provides key financial performance indicators and operational updates. Investors should note that this filing is furnished, not deemed "filed," meaning it does not carry the same legal liabilities as a fully filed document. The attached press release (Exhibit 99.1) is the primary source of information regarding the company's performance during the specified quarter and should be reviewed for detailed financial figures and management commentary.
LAM RESEARCH CORP 8-K Report, Material Agreement (Jun 21, 2021)
Lam Research Corporation (LRCX) has filed an 8-K report on June 21, 2021, detailing the entry into a Second Amended and Restated Credit Agreement, effective June 17, 2021. This agreement primarily serves to increase the company's revolving unsecured credit facility from $1.250 billion to $1.500 billion, with an option to expand it further by up to $600 million, potentially reaching a total of $2.1 billion. This enhanced liquidity provides the company with greater financial flexibility for general corporate purposes. The new credit facility matures on June 17, 2026, and includes provisions for interest rates based on either a base rate or LIBOR, with spreads influenced by the company's debt rating and sustainability performance metrics. The agreement also incorporates standard covenants, including financial covenants such as maintaining a consolidated debt to adjusted EBITDA ratio of less than or equal to 3.50 to 1.00. The report also notes that some lenders are existing financial service providers to Lam Research.
LAM RESEARCH CORP 8-K Report, Financial Results (Apr 21, 2021)
Lam Research Corporation (LRCX) filed an 8-K on April 21, 2021, to announce its financial results for the fiscal quarter ended March 28, 2021. The filing includes a press release with these results, which investors should review for detailed operational and financial performance metrics. This report primarily serves to disclose the company's performance for the specified quarter. Investors are directed to the attached Exhibit 99.1 for the complete financial information. The company emphasizes that the information provided is furnished and not deemed 'filed' for regulatory purposes, which is a standard disclosure for such reports.
LAM RESEARCH CORP 8-K Report, Regulation FD Disclosure (Mar 19, 2021)
Lam Research Corporation (LRCX) filed an 8-K on March 19, 2021, primarily to disclose information regarding an adjustment to the conversion rate of its 2.625% Senior Convertible Notes due 2041. This adjustment was made pursuant to the indenture governing these notes and was communicated to the noteholders on March 19, 2021. While this filing does not contain material financial updates or operational changes, it's important for holders of these specific convertible notes to be aware of any adjustments that could impact their conversion rights or the value of their holdings.
LAM RESEARCH CORP 8-K Report, Financial Results (Jan 27, 2021)
Lam Research Corporation (LRCX) filed an 8-K on January 27, 2021, primarily to report its financial results for the fiscal quarter ended December 27, 2020. The filing includes a press release announcing these results, which is furnished as an exhibit. While this 8-K doesn't contain extensive operational details within the report itself, it serves as the official channel for disseminating the company's latest financial performance to investors and the market. Investors should refer to the attached press release (Exhibit 99.1) for the specific financial metrics, including revenue, profitability, and any forward-looking guidance provided by the company. This is a standard procedure for publicly traded companies to ensure timely and regulated disclosure of material financial information. The information furnished is not considered "filed" for certain legal purposes, but it remains crucial for understanding the company's ongoing financial condition and operational trajectory.
LAM RESEARCH CORP 8-K Report, Executive Changes (Dec 28, 2020)
Lam Research Corporation (LRCX) filed an 8-K on December 28, 2020, to announce the adoption of a new Executive Severance Policy and an Executive Change in Control Policy, effective January 1, 2021. These new policies will supersede existing employment and change-in-control agreements for senior executives, which are set to expire at the end of 2020. The primary purpose of this filing is to outline the updated compensation and benefits provided to key executives under specific termination scenarios, including involuntary termination, termination related to an acquisition, disability, or death. Investors should note that these policies define the severance packages, including cash payments, medical benefits, and accelerated vesting of equity awards (stock options and RSUs), for "Covered Executives" and specific "Tier 1 Executives" (CEO, President, EVP). The details vary based on the nature of the termination and whether a change in control or acquisition is involved, with higher multiples of salary and incentive compensation provided in change-in-control or acquisition-related scenarios. The policies also include provisions for confidentiality, non-compete, and non-solicitation obligations, and are subject to compensation recovery policies.
LAM RESEARCH CORP 8-K Report, Regulation FD Disclosure (Dec 11, 2020)
Lam Research Corporation (LRCX) filed an 8-K on December 11, 2020, to disclose an adjustment to the conversion rate of its 2.625% Senior Convertible Notes due 2041. This adjustment was made pursuant to the indenture governing these notes. While the specific reasons for the adjustment are not detailed in this filing, it's important for holders of these notes to be aware of this change as it impacts the terms under which the notes can be converted into company stock. Investors holding these convertible notes should review the "Notice of Adjustment of Conversion Rate" attached as Exhibit 99.1 to understand the precise details of the adjustment and its potential implications for their investment. The company is furnishing this information under Regulation FD and clarifies that it is not considered "filed" for purposes of liability under the Securities Exchange Act, nor is it incorporated by reference into other filings unless explicitly stated.
LAM RESEARCH CORP 8-K Report, Shareholder Vote Results (Nov 5, 2020)
Lam Research Corporation (LRCX) filed an 8-K on November 4, 2020, reporting on its Annual Meeting of Stockholders held on November 3, 2020. The key outcomes include the overwhelming approval of all director nominees, a "Say on Pay" proposal endorsing executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2021. Significantly, the company also announced on November 5, 2020, a substantial $5 billion share repurchase authorization. This move signals strong confidence from management in the company's financial position and future prospects, suggesting a commitment to returning capital to shareholders. Investors should view these developments positively as they indicate robust governance and a strategic financial management approach.
LAM RESEARCH CORP 8-K Report, Financial Results (Oct 21, 2020)
Lam Research Corporation (LRCX) filed an 8-K on October 21, 2020, to report its financial results for the fiscal quarter ended September 27, 2020. The filing primarily serves to attach the press release containing these results, which is furnished rather than deemed 'filed' under SEC regulations. Investors should refer to the attached press release (Exhibit 99.1) for detailed financial performance and operational updates. This report signals the company's adherence to its reporting schedule and provides investors with timely information regarding its quarterly performance. The key takeaway for investors is to access the press release to understand the specific revenue, profit, and other financial metrics for the period, which will inform their assessment of the company's current business trajectory and future outlook.
LAM RESEARCH CORP 8-K Report, Regulation FD Disclosure (Oct 2, 2020)
Lam Research Corporation (LRCX) filed an 8-K on October 2, 2020, to disclose an adjustment to the conversion rate of its 2.625% Senior Convertible Notes due 2041. This adjustment was made in accordance with the terms of the indenture governing these notes, which were originally issued by Novellus Systems, Inc. While this filing is primarily for informational purposes under Regulation FD, it signifies a corporate action directly impacting the terms of outstanding convertible debt. Investors holding these specific convertible notes should review the details of the conversion rate adjustment. Although the filing does not provide specific financial results or forward-looking guidance, it is a material event for holders of the 2041 Notes, as it changes the number of shares into which each note can be converted. The company has furnished this information and explicitly stated it is not deemed "filed" for liability purposes under the Exchange Act, but it remains a key piece of information for relevant bondholders.